1. Home
  2. ACIU vs ANGI Comparison

ACIU vs ANGI Comparison

Compare ACIU & ANGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AC Immune SA

ACIU

AC Immune SA

HOLD

Current Price

$2.76

Market Cap

247.6M

Sector

Health Care

ML Signal

HOLD

Logo Angi Inc.

ANGI

Angi Inc.

HOLD

Current Price

$4.72

Market Cap

198.7M

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACIU
ANGI
Founded
2003
1995
Country
Switzerland
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Advertising
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
247.6M
198.7M
IPO Year
2015
2017

Fundamental Metrics

Financial Performance
Metric
ACIU
ANGI
Price
$2.76
$4.72
Analyst Decision
Strong Buy
Buy
Analyst Count
2
7
Target Price
$10.00
$17.00
AVG Volume (30 Days)
194.4K
764.9K
Earning Date
05-12-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
1242.86
EPS
N/A
N/A
Revenue
N/A
$736,386,000.00
Revenue This Year
$706.75
$3.25
Revenue Next Year
$321.13
$3.76
P/E Ratio
N/A
N/A
Revenue Growth
N/A
47.60
52 Week Low
$2.10
$4.26
52 Week High
$4.00
$18.38

Technical Indicators

Market Signals
Indicator
ACIU
ANGI
Relative Strength Index (RSI) 51.79 43.93
Support Level $2.57 $4.55
Resistance Level $3.00 $6.52
Average True Range (ATR) 0.15 0.30
MACD -0.01 0.03
Stochastic Oscillator 27.38 19.08

Price Performance

Historical Comparison
ACIU
ANGI

About ACIU AC Immune SA

AC Immune SA is a clinical stage biopharmaceutical company advancing a portfolio of programs strategically focused on pioneering Precision Medicine for neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The company has one segment. The company currently focuses mostly of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.

About ANGI Angi Inc.

Angi Inc connects quality home service professionals with consumers across different categories, from repairing and remodeling to cleaning and landscaping. It operates through brands like Angi, HomeAdvisor, and Handy. The company has three operating segments, namely, Ads and Leads, Services, and International (Europe and Canada). A majority of its revenue is generated from the Ads and Leads segment, which provides professionals the capability to engage with potential customers, including quoting and invoicing services, and provides consumers with tools and resources to help them find professionals nationwide for home repair, maintenance, and improvement projects. Geographically, the company derives its key revenue from the United States and also has a presence in other countries.

Share on Social Networks: